Literature DB >> 22359369

Mood disorders in inflammatory bowel disease: relation to diagnosis, disease activity, perceived stress, and other factors.

J R Goodhand1, M Wahed, J E Mawdsley, A D Farmer, Q Aziz, D S Rampton.   

Abstract

BACKGROUND: Anxiety and depression are common in patients with inflammatory bowel disease (IBD); however, the factors associated with mood disorders in patients with ulcerative colitis (UC) and Crohn's disease (CD) are poorly defined.
METHODS: In all, 103 patients with UC, 101 with CD, and 124 healthy controls completed the Hospital Anxiety and Depression Scale (HADS). Disease activity was defined both from symptom scores and in UC endoscopically, and in CD by fecal calprotectin and/or serum C-reactive protein. Multivariate regression analyses were used to identify factors associated with anxiety and depression.
RESULTS: In both UC and CD, anxiety (HADS-A) and depression (HADS-D) scores were higher than in controls (HADS-A: 8.5 ± 4.1 [mean ± SD], 8.6 ± 3.9, 3.2 ± 1.8, P < 0.001; and HADS-D: 4.1 ± 3.3, 4.7 ± 3.3, 1.7 ± 1.4, P < 0.001, respectively). There were no differences in the prevalence of mild, moderate, and severe anxiety and depression in UC and CD. In UC, anxiety scores were associated with perceived stress and a new diagnosis of IBD; depression was associated with stress, inpatient status, and active disease. In CD, anxiety was associated with perceived stress, abdominal pain, and lower socioeconomic status, and depression with perceived stress and increasing age.
CONCLUSIONS: Anxiety and depression are common in IBD. Perceived stress is associated with mood disturbances in both UC and CD, but the other associated factors differ in the two diseases. Gastroenterologists should look for mood disorders in IBD and consider stress management and psychotherapy in affected patients.
Copyright © 2012 Crohn's & Colitis Foundation of America, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22359369     DOI: 10.1002/ibd.22916

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  73 in total

1.  Anxiety, depression, and inflammation after restorative proctocolectomy.

Authors:  Venkata Subhash Gorrepati; Sanjay Yadav; August Stuart; Walter Koltun; Evangelos Messaris; Emmanuelle D Williams; Matthew D Coates
Journal:  Int J Colorectal Dis       Date:  2018-06-29       Impact factor: 2.571

Review 2.  Epidemiology and risk factors for IBD.

Authors:  Ashwin N Ananthakrishnan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-03-03       Impact factor: 46.802

Review 3.  Non-pharmacological therapies for inflammatory bowel disease: Recommendations for self-care and physician guidance.

Authors:  Whitney Duff; Natasha Haskey; Gillian Potter; Jane Alcorn; Paulette Hunter; Sharyle Fowler
Journal:  World J Gastroenterol       Date:  2018-07-28       Impact factor: 5.742

Review 4.  ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease.

Authors:  Francis A Farraye; Gil Y Melmed; Gary R Lichtenstein; Sunanda V Kane
Journal:  Am J Gastroenterol       Date:  2017-01-10       Impact factor: 10.864

5.  Psychiatric comorbidities in patients with inflammatory bowel disease.

Authors:  Rasika Bhamre; Sangeet Sawrav; Shilpa Adarkar; Rishika Sakaria; Shobna J Bhatia
Journal:  Indian J Gastroenterol       Date:  2018-09-08

6.  Perianal disease is associated with psychiatric co-morbidity in Crohn's disease in remission.

Authors:  Giovanni Maconi; Daniele Gridavilla; Caterina Viganò; Roberta Sciurti; Anil K Asthana; Federica Furfaro; Federica Re; Sandro Ardizzone; Gabriella Ba
Journal:  Int J Colorectal Dis       Date:  2014-07-02       Impact factor: 2.571

7.  Treatment with immunosuppressive therapy may improve depressive symptoms in patients with inflammatory bowel disease.

Authors:  Sara Horst; Andrew Chao; Michael Rosen; Anne Nohl; Caroline Duley; Julianne H Wagnon; Dawn B Beaulieu; Warren Taylor; Lawrence Gaines; David A Schwartz
Journal:  Dig Dis Sci       Date:  2014-10-02       Impact factor: 3.199

8.  Environmental influences on the onset and clinical course of Crohn's disease-part 1: an overview of external risk factors.

Authors:  Aamir N Dam; Adam M Berg; Francis A Farraye
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-11

Review 9.  British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.

Authors:  Christopher Andrew Lamb; Nicholas A Kennedy; Tim Raine; Philip Anthony Hendy; Philip J Smith; Jimmy K Limdi; Bu'Hussain Hayee; Miranda C E Lomer; Gareth C Parkes; Christian Selinger; Kevin J Barrett; R Justin Davies; Cathy Bennett; Stuart Gittens; Malcolm G Dunlop; Omar Faiz; Aileen Fraser; Vikki Garrick; Paul D Johnston; Miles Parkes; Jeremy Sanderson; Helen Terry; Daniel R Gaya; Tariq H Iqbal; Stuart A Taylor; Melissa Smith; Matthew Brookes; Richard Hansen; A Barney Hawthorne
Journal:  Gut       Date:  2019-09-27       Impact factor: 23.059

Review 10.  The mucosal immune system: master regulator of bidirectional gut-brain communications.

Authors:  Nick Powell; Marjorie M Walker; Nicholas J Talley
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-01-18       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.